Recor Medical today announced results from two clinical studies evaluating its Paradise ultrasound renal denervation (uRDN) ...
Philips (NYSE: PHG) today announced results from the iMODERN trial evaluating immediate versus delayed treatment of narrowed ...
Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional ...
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and ...
This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, ...
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are less likely to suffer heart ...
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...
Technique may be a valuable add-on procedure for patients with weak heart function after a heart attack, say ...
Interesting Engineering on MSN
Microcatheter navigates arteries thinner than human hair to deliver lifesaving therapies
In a medical robotics breakthrough, scientists at the Swiss Federal Institute of Technology Lausanne (EPFL) have built a new ...
Ryan Reynolds has made a life-changing donation to help a mother afford her baby Ollie’s critical surgery. Ollie was born ...
Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback